MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹533 Cr | ₹459 Cr | ₹339 Cr | ₹259 Cr | ₹340 Cr |
What is the latest Operating Profit of MARKSANS PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹533 Cr |
| Mar2025 | ₹459 Cr |
| Mar2024 | ₹339 Cr |
| Mar2023 | ₹259 Cr |
| Mar2022 | ₹340 Cr |
How is Operating Profit of MARKSANS PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹533 Cr | 16.16 | |
| Mar2025 | ₹459 Cr | 35.15 | |
| Mar2024 | ₹339 Cr | 31.07 | |
| Mar2023 | ₹259 Cr | -23.77 | |
| Mar2022 | ₹340 Cr | - | |
Compare Operating Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,636.1 Cr | 1.7% | 27.4% | 81.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.7% |
27.4% |
81.2% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses